Biomerieux SA

Biomerieux SA is a company in Marcy-l'Etoile, France that has taken part in 21 EU-funded projects since 2014, receiving €4.5M in EU funding.

EU funding received€4.5M
EU projects21
As coordinator0
Running now9
First EU project2014
Latest project2026
CountryFrance
EU registration (PIC)973654088
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Biomerieux SA's own share of each project, not the project's full budget.

  • Horizon 2020€3.6M · 11 projects
  • Horizon Europe€700k · 7 projects
  • FP7 (2007 to 2013)€203k · 1 project
  • Erasmus+ (ERASMUS+)€0 · 2 projects

Projects

21 EU-funded projects, newest first. Each links to the official record.

  • FORTIFYPartner

    FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • MedTechLabelPartner

    MedTechLabel: UNIFIED DIGITAL LABELLING FOR MEDICAL TECHNOLOGY PRODUCTS

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • JANUSAssociated partner

    Joint master in Applied security and defense - Networks for Unified Strategies

    Erasmus+ (ERASMUS+) · 2025–2031 · Project on the EU portal ↗

  • MALDIBANKPartner

    Multi-domain Open MALDI Spectra Archive for Identification of Microorganisms

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €58ktheir share
  • PROACT EU-ResponsePartner

    A European Proactive Adaptive Clinical Trials Network within EU-Response

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €166ktheir share
  • LIVE_InnovAssociated partner

    Leading International Vaccinology Education for Innovation

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • MICROORCPartner

    MICROORC: ORCHESTRATING FOOD SYSTEM MICROBIOMES TO MINIMIZE FOOD WASTE

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €231ktheir share
  • SYNSENSOAssociated partner

    Cell-free synthetic biology for combinatorial biosensor design

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

  • UNDINEPartner

    The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €246ktheir share
  • TTV GUIDE TXPartner

    PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €802ktheir share
  • ImmunoSepPartner

    Personalized immunotherapy in sepsis: a precision medicine based approach

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €400ktheir share
  • DIAMONDSPartner

    Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €400ktheir share
  • VALUE-DxPartner

    The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  • VITALPartner

    Vaccines and Infectious Diseases in the Ageing PopuLation

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  • ViBrANTPartner

    VIral and BacteRial Adhesin Network Training

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €526ktheir share
  • COMBACTE-CDIPartner

    Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  • ND4IDPartner

    New Diagnostics for Infectious Diseases: “ND4ID”

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €526ktheir share
  • ESA -ITNPartner

    European Sepsis Academy: towards new biomarkers to improve sepsis management

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €526ktheir share
  • PERFORMPartner

    Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €400ktheir share
  • CLOSPOREPartner

    UNDERSTANDING THE CLOSTRIDIUM SPORE, A PREREQUISTE FOR DISEASE INTERVENTIONS AND EXPLOITATION

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • PREPAREPartner

    Platform foR European Preparedness Against (Re-)emerging Epidemics

    FP7 (2007 to 2013) · 2014–2021 · Project on CORDIS ↗

    €203ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • antibiotic resistance
  • antibiotics
  • bacteriology
  • cell biology
  • clinical medicine
  • coronaviruses
  • data processing
  • databases
  • diagnostic technologies
  • ecosystems
  • epidemiology
  • genetics
  • governance

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime